SE8702734D0 - Monoclonal antibodies to pseudomonas aeruginosa flagella - Google Patents

Monoclonal antibodies to pseudomonas aeruginosa flagella

Info

Publication number
SE8702734D0
SE8702734D0 SE8702734A SE8702734A SE8702734D0 SE 8702734 D0 SE8702734 D0 SE 8702734D0 SE 8702734 A SE8702734 A SE 8702734A SE 8702734 A SE8702734 A SE 8702734A SE 8702734 D0 SE8702734 D0 SE 8702734D0
Authority
SE
Sweden
Prior art keywords
monoclonal antibodies
pseudomonas aeruginosa
antibodies
aeruginosa flagella
flagella
Prior art date
Application number
SE8702734A
Other languages
English (en)
Other versions
SE506421C2 (sv
SE8702734L (sv
Inventor
M E Lostrom
A W Siadak
M J Rosok
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/946,554 external-priority patent/US4834976A/en
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of SE8702734D0 publication Critical patent/SE8702734D0/sv
Publication of SE8702734L publication Critical patent/SE8702734L/sv
Publication of SE506421C2 publication Critical patent/SE506421C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE8702734A 1986-07-03 1987-07-02 Monoklonala antikroppar mot Pseudomonas aeruginosa och beredningar innehållande dessa, testsats innehållande beredningen, samt cellinjer uttryckande antikropparna SE506421C2 (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88198486A 1986-07-03 1986-07-03
US06/946,554 US4834976A (en) 1986-07-03 1986-12-24 Monoclonal antibodies to pseudomonas aeruginosa flagella
US4814387A 1987-05-15 1987-05-15

Publications (3)

Publication Number Publication Date
SE8702734D0 true SE8702734D0 (sv) 1987-07-02
SE8702734L SE8702734L (sv) 1988-01-04
SE506421C2 SE506421C2 (sv) 1997-12-15

Family

ID=27367280

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8702734A SE506421C2 (sv) 1986-07-03 1987-07-02 Monoklonala antikroppar mot Pseudomonas aeruginosa och beredningar innehållande dessa, testsats innehållande beredningen, samt cellinjer uttryckande antikropparna

Country Status (19)

Country Link
JP (1) JP2639422B2 (sv)
KR (1) KR910002373B1 (sv)
AT (1) AT399885B (sv)
AU (1) AU615162B2 (sv)
BE (1) BE1000743A3 (sv)
CH (1) CH677796A5 (sv)
DE (1) DE3722098C2 (sv)
DK (1) DK172840B1 (sv)
ES (1) ES2013321A6 (sv)
FR (1) FR2601458B1 (sv)
GB (1) GB2192185B (sv)
IE (1) IE60888B1 (sv)
IL (1) IL83047A (sv)
IT (1) IT1221940B (sv)
LU (1) LU86938A1 (sv)
NL (1) NL194961C (sv)
OA (1) OA08629A (sv)
PT (1) PT85247B (sv)
SE (1) SE506421C2 (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
NZ218499A (en) * 1985-12-10 1990-04-26 Genetic Systems Corp Monoclonal antibodies against pseudomonas aeruginosa, pharmaceutical compositions and detection methods
AU615162B2 (en) * 1986-07-03 1991-09-26 Genetic Systems Corporation Monoclonal antibodies to pseudomonas aeruginosa flagella
CA1341375C (en) * 1988-10-12 2002-07-09 Baxter International Inc. Compositions and methods for the treatment and prevention of gram-negative bacterial infections
JPH02299594A (ja) * 1989-01-30 1990-12-11 Sumitomo Chem Co Ltd ヒトモノクローナル抗体およびその製法
WO1990013033A1 (en) * 1989-04-14 1990-11-01 Biocontrol Systems, Incorporated Process and device for detecting a particular motile organism
WO1991010743A1 (en) * 1990-01-18 1991-07-25 Cura Nominees Pty Ltd Glycoalkaloids
WO2010091189A1 (en) * 2009-02-04 2010-08-12 Kalobios Pharmaceuticals, Inc. Combination antibiotic and antibody therapy for the treatment of pseudomonas aeruginosa infection
WO2011107989A1 (en) * 2010-03-01 2011-09-09 Lostam Biopharmaceuticals Ltd Improved therapeutic antibodies against flagellated pseudomonas aeruginosa

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8422649D0 (en) * 1984-09-07 1984-10-10 Technology Licence Co Ltd Monoclonal antibodies
JP2691708B2 (ja) * 1984-09-26 1997-12-17 住友製薬株式会社 ヒトモノクローナル抗体およびその製法
WO1986007382A1 (en) * 1985-06-06 1986-12-18 Genetic Systems Corporation Protective human monoclonal antibodies to pseudomonas aeruginosa exotoxin a
EP0211352B1 (en) * 1985-08-01 1994-03-16 Miles Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4918163A (en) * 1985-09-27 1990-04-17 Pfizer Inc. Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria
ZA868673B (en) * 1985-12-10 1988-07-27 Genetic Systems Corp Monoclonal antibodies cross-reactive and cross-protective against p.aeruginosa serotypes
NZ218499A (en) * 1985-12-10 1990-04-26 Genetic Systems Corp Monoclonal antibodies against pseudomonas aeruginosa, pharmaceutical compositions and detection methods
AU615162B2 (en) * 1986-07-03 1991-09-26 Genetic Systems Corporation Monoclonal antibodies to pseudomonas aeruginosa flagella

Also Published As

Publication number Publication date
NL194961B (nl) 2003-05-01
IL83047A0 (en) 1987-12-31
DK172840B1 (da) 1999-08-09
GB2192185A (en) 1988-01-06
NL194961C (nl) 2003-09-02
FR2601458A1 (fr) 1988-01-15
SE506421C2 (sv) 1997-12-15
LU86938A1 (fr) 1988-02-02
KR880001815A (ko) 1988-04-27
GB8715347D0 (en) 1987-08-05
IT8721163A0 (it) 1987-07-02
PT85247B (pt) 1990-06-29
AU7495887A (en) 1988-01-07
IE871769L (en) 1988-01-03
IE60888B1 (en) 1994-08-24
BE1000743A3 (fr) 1989-03-28
ES2013321A6 (es) 1990-05-01
JP2639422B2 (ja) 1997-08-13
NL8701554A (nl) 1988-02-01
GB2192185B (en) 1991-01-16
FR2601458B1 (fr) 1992-08-21
DE3722098C2 (de) 1998-06-04
IL83047A (en) 1992-12-01
AT399885B (de) 1995-08-25
CH677796A5 (sv) 1991-06-28
JPS63102697A (ja) 1988-05-07
AU615162B2 (en) 1991-09-26
DK336687A (da) 1988-01-04
DK336687D0 (da) 1987-06-30
KR910002373B1 (ko) 1991-04-20
PT85247A (en) 1987-08-01
DE3722098A1 (de) 1988-03-03
OA08629A (en) 1988-11-30
ATA168387A (de) 1994-12-15
IT1221940B (it) 1990-08-31
SE8702734L (sv) 1988-01-04

Similar Documents

Publication Publication Date Title
SE8700498D0 (sv) Novel pharmaceologically active compounds
EA199800946A1 (ru) Концентрированный препарат антител
ATE240395T1 (de) Antikörper gegen e-selektin
SE8605295D0 (sv) Monoclonal antibodies cross-reactive and crossprotective against p. aeruginosa serotypes
ES2062355T3 (es) Composicion farmaceutica que comprende loratadina, ibuprofeno y pseudoefedrina.
NO964966D0 (no) Lactobacillusstammer av human opprinnelse, blandinger samt anvendelse derav
NO831084L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kvartaere dibenzotiepin-n-alkyl-norskopinetere
PT817847E (pt) Receptor de il-17
NO962346L (no) Humaniserte antistoffer og anvendelser derav
DE60125797D1 (de) Impfstoffzusammesetzung
DK0705100T3 (da) Terapeutiske substituerede guanidiner
DE69905170T2 (de) Thiazolopyrimidinderivate
GR1000118B (el) Συνθεσις 1,2-διοξετανων & ενδιαμεσαι ουσιαι δι αυτην.
DK0858504T3 (da) Diagnostiske midler mod og behandlinger af periodontale sygdomme
SE8700467D0 (sv) Cross-protective human monoclonal antibody compositions
SE8702734D0 (sv) Monoclonal antibodies to pseudomonas aeruginosa flagella
DE69230798T2 (de) Rekombinante immuntoxine
DE69426767D1 (de) Anti idiotypische Antikörper gegen Gonococcen und diese verwendende Verfahren und Zusammensetzungen.
EA200400670A1 (ru) Фармацевтические композиции, содержащие 3,4-пропинопергидропурины, и их применение для блокирования нейронной передачи
AU584690B2 (en) E87ag antigen of pseudomonas aeruginosa, monoclonal antibody against it, and hybridoma
ES8707296A1 (es) Un metodo para producir anticuerpos monoclonales humanos
FI800350A (fi) Dehydropeptider foerfarande foer framstaellning av dessa samt anvaendningen av dessa som laekemedel
DK319384A (da) 1-0-alkyl-3-amino-propan-1,2-diol-2-0-phospholipider, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende disse
ATE239499T1 (de) Protein-disulfid-isomerasen enthaltende pharmazeutische zusammensetzungen
IT1254742B (it) Impiego della beta-endorfina quale farmaco immunosoppressore nei trapianti d'organo

Legal Events

Date Code Title Description
NUG Patent has lapsed